637336-53-9

Basic information

• Product Name: 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI)
• Synonyms: 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI);Methyl 4-aMino-1-Methyl-1h-pyrazole-3-carboxylate;1-Methyl-4-amino-1H-pyrazol-3-carboxylic acid methyl ester
• CAS NO: 637336-53-9
• Molecular Formula: C₆H₉N₃O₂
• Molecular Weight: 155.15
• Product Categories: GLYCINESCAFFOLD;CARBOXYLICESTER
• Mol File: 637336-53-9.mol
• Article Data: 19

Chemical Properties

• Melting Point: 99-104 °C(Solv: cyclohexane (110-82-7))
• Boiling Point: 288.6°C at 760 mmHg
• Flash Point: 128.3°C
• Appearance: /
• Density: 1.35g/cm³
• Vapor Pressure: 0.00232mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: 2-8°C(protect from light)
• PKA: 1.28±0.10(Predicted)
• CAS DataBase Reference: 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI)(637336-53-9)
• EPA Substance Registry System: 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI)(637336-53-9)

Safety Data

• Hazardous Substances Data: 637336-53-9(Hazardous Substances Data)

Usage

General Description

1H-Pyrazole-3-carboxylic acid, 4-amino-1-methyl-, methyl ester (9CI) is a chemical compound that belongs to the pyrazole class of compounds. It is characterized by the presence of a pyrazole ring with a carboxylic acid and an amino group, as well as a methyl ester functional group. 1H-Pyrazole-3-carboxylicacid,4-amino-1-methyl-,methylester(9CI) has potential applications in various fields such as pharmaceuticals, agrochemicals, and materials science. It may be used as a building block for the synthesis of other organic compounds, and its properties make it suitable for use in drug discovery and development. Additionally, it may have potential uses in the development of new materials and in agricultural applications. Understanding the properties and potential applications of 1H-Pyrazole-3-carboxylic acid, 4-amino-1-methyl-, methyl ester (9CI) is important for further research and development in these areas.

InChI:InChI=1/C6H9N3O2/c1-9-3-4(7)5(8-9)6(10)11-2/h3H,7H2,1-2H3

Upstream product

• 138786-86-4 methyl 4-nitro-1H-pyrazole-3-carboxylate 
• 74-88-4 methyl iodide 
• 4598-86-1 1-methyl-4-nitro-1H-pyrazole-3-carboxylic acid 
• 400877-57-8 1-methyl-4-nitro-1H-pyrazole-3-carboxylic acid methyl ester 

Downstream Products

• 96256-54-1 methyl 1-methyl-4-phenyl-1H-pyrazole-3-carboxylate 
• 1021497-88-0 4-[2-(4-bromo-phenylsulfanyl)-acetylamino]-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester 
• 1021497-89-1 4-[2-phenylsulfanylacetylamino]-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester 

Relevant articles and documents

Piperidine compound and preparation method and medical application thereof

The invention discloses a piperidine compound shown as a formula (I) and a preparation method and medical application thereof, and particularly relates to a piperidine USP7 inhibitor compound or pharmaceutically acceptable salt or ester or solvate thereof and a preparation method and application of the piperidine USP7 inhibitor compound or pharmaceutically acceptable salt or ester or solvate thereof. The compound provided by the invention can inhibit the activity of USP7 enzyme, has very good selectivity and druggability, and can be used for preparing medicines for preventing or treating tumor diseases or virus infectious diseases.

Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity in Vivo

The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways of the cannabinoid type-2 receptor (CB2R) can represent a helpful option in the treatment of OA. In this perspective, a set of 18 cannabinoid type-2 receptor (CB2R) ligands was developed based on an unprecedented structure. With the aim of improving the physicochemical properties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization program led to the discovery of isosteric 7-hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide derivatives. These new compounds are endowed with high affinity for the CB2R and moderate to good selectivity over the cannabinoid type-1 receptor (CB1R), associated with good physicochemical characteristics. As to the functional activity at the CB2R, compounds able to act either as agonists or as inverse agonists/antagonists were discovered. Among them, compound 51 emerged as a potent CB2R agonist able to reduce pain in rats carrying OA induced by injection of monoiodoacetic acid (MIA).

SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

There is provided a compound of formula (I), wherein L1 to L3, R1 to R4, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.